Hochnadel, I., Hoenicke, L., Petriv, N., Suo, H., Groebe, L., Olijnik, C., . . . Yevsa, T. In vivo RNAi screen and validation reveals Ngp, Hba-a1, and S100a8 as novel inhibitory targets on T lymphocytes in liver cancer. Frontiers Media S.A.
Chicago Style (17th ed.) CitationHochnadel, Inga, et al. In Vivo RNAi Screen and Validation Reveals Ngp, Hba-a1, and S100a8 as Novel Inhibitory Targets on T Lymphocytes in Liver Cancer. Frontiers Media S.A.
MLA (9th ed.) CitationHochnadel, Inga, et al. In Vivo RNAi Screen and Validation Reveals Ngp, Hba-a1, and S100a8 as Novel Inhibitory Targets on T Lymphocytes in Liver Cancer. Frontiers Media S.A.
Warning: These citations may not always be 100% accurate.